|
Market Closed -
Nasdaq
01:30:00 24/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 87.73 USD | -2.01% |
|
+0.45% | +32.18% |
| 17/09 | Truist Securities Adjusts DexCom Price Target to $102 From $93, Maintains Buy Rating | MT |
| 17/09 | Dexcom Insider Sold Shares Worth $679,769, According to a Recent SEC Filing | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Medical Equipment, Supplies & Distribution
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 3.38TCr | |||||
| 18TCr | |||||
| 12TCr | |||||
| 6TCr | |||||
| 4.98TCr | |||||
| 4.8TCr |
- Stock Market
- Stocks
- DXCM Stock
- Charts DexCom, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
